A new coronavirus associated with human respiratory disease in China

Cited by (1,042)

Items 401–500 of 1,042

1. HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19
   Mingfu Tian, Weiyong Liu, Xiang Li, Peiyi Zhao, Muhammad Adnan Shereen, Chengliang Zhu, Shanyu Huang, Siyu Liu, Xiao Yu, Miaomiao Yue et al. · 2021 · Signal Transduction and Targeted Therapy
2. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2
   Yinghui Liu, Gaowei Hu, Yuyan Wang, Wenlin Ren, Xiaomin Zhao, Fansen Ji, Yunkai Zhu, Fei Feng, Mingli Gong, Xiaohui Ju et al. · 2021 · Proceedings of the National Academy of Sciences
3. Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease
   Mingzhi Li, Pinggui Lei, Bingliang Zeng, Zongliang Li, Peng Cheng Yu, Bing Fan, Chuanhong Wang, Zicong Li, Jian Zhou, Shaobo Hu et al. · 2020 · Academic Radiology
4. What dentists need to know about COVID-19
   Maryam Baghizadeh Fini · 2020 · Oral Oncology
5. Zoonotic spillover: Understanding basic aspects for better prevention
   Joel Henrique Ellwanger, José Artur Bogo Chies · 2021 · Genetics and Molecular Biology
6. The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2
   Jonathan E. Pekar, Andrew F. Magee, Edyth Parker, Niema Moshiri, Katherine Izhikevich, Jennifer L. Havens, Karthik Gangavarapu, Lorena M. Malpica Serrano, Alexander Crits‐Christoph, Nathaniel L. Matteson et al. · 2022 · Science
7. Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads
   Yang Pan, Luyao Long, Daitao Zhang, Tingting Yuan, Shujuan Cui, Peng Yang, Quanyi Wang, Simei Ren · 2020 · Clinical Chemistry
8. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19
   Qirui Guo, Yingchi Zhao, Junhong Li, Jiangning Liu, Xiuhong Yang, Xuefei Guo, Ming Kuang, Huawei Xia, Zeming Zhang, Lili Cao et al. · 2020 · Cell Host & Microbe
9. Emerging Adults and COVID-19: The Role of Individualism-Collectivism on Perceived Risks and Psychological Maladjustment
   Alessandro Germani, Livia Buratta, Elisa Delvecchio, Claudia Mazzeschi · 2020 · International Journal of Environmental Research and Public Health
10. Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays
    Edward I. Patterson, Tessa Prince, Enyia R. Anderson, Aitor Casas-Sánchez, Shirley L. Smith, Cintia Cansado-Utrilla, Tom Solomon, Michael John Griffiths, Álvaro Acosta-Serrano, Lance C. W. Turtle et al. · 2020 · The Journal of Infectious Diseases
11. Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China
    Jing Lu, Louis du Plessis, Zhe Liu, Verity Hill, Min Kang, Huifang Lin, Jiufeng Sun, Sarah François, Moritz U. G. Kraemer, Nuno Rodrigues Faria et al. · 2020 · Cell
12. Growth, detection, quantification, and inactivation of SARS-CoV-2
    James Brett Case, Adam L. Bailey, Arthur S. Kim, Rita E. Chen, Michael Diamond · 2020 · Virology
13. Host genetics and infectious disease: new tools, insights and translational opportunities
    Andrew John Kwok, Alexander J. Mentzer, Julian Charles Knight · 2020 · Nature Reviews Genetics
14. Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV‑2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
    Chunhui Zhang, Elizabeth A. Stone, Maya G. Deshmukh et al. · 2021 · ACS Central Science
15. SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways
    Lulu Han, Meng‐Wei Zhuang, Jian Deng, Yi Zheng, Jing Zhang, Mei‐Ling Nan, Xuejing Zhang, Chengjiang Gao, Pei‐Hui Wang · 2021 · Journal of Medical Virology
16. The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes
    Yabin Zhang, Hao Sun, Rongjuan Pei, Binli Mao, Zhenyu Zhao, Huihui Li, Yong Lin, Kefeng Lu · 2021 · Cell Discovery
17. Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
    Kangsa Amporndanai, Xiaoli Meng, Weijuan Shang, Zhenming Jin, Michael Rogers, Yao Zhao, Zihe Rao, Zhi‐Jie Liu, Haitao Yang, Leike Zhang et al. · 2021 · Nature Communications
18. Innate immune evasion strategies of SARS-CoV-2
    Judith M. Minkoff, Benjamin Robert tenOever · 2023 · Nature Reviews Microbiology
19. Therapeutic management of patients with COVID-19: a systematic review
    Mansour A. Tobaiqy, Mohammed Esmail Qashqary, Shrooq T. Aldahery, Alaa Mujallad, Almonther Abdullah Hershan, Mohammad Azhar Kamal, Nawal Mohammed Helmi · 2020 · Infection Prevention in Practice
20. Humoral Responses and Serological Assays in SARS-CoV-2 Infections
    Yannick Galipeau, Matthew Greig, Chaojie Liu, Matt Driedger, Marc‐André Langlois · 2020 · Frontiers in Immunology
21. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
    Elizabeth R. Mann, Madhvi Menon, Sean Knight, Joanne Elizabeth Konkel, Christopher P. Jagger, Tovah N. Shaw, Siddharth Krishnan, Magnus Rattray, Andrew Ustianowski, Nawar Diar Bakerly et al. · 2020 · Science Immunology
22. Opposing activities of IFITM proteins in SARS‐CoV‐2 infection
    Guoli Shi, Adam D. Kenney, Elena Kudryashova, Ashley Zani, Lizhi Zhang, Kin Kui Lai, Luanne Hall‐Stoodley, Richard Robinson, Dmitri S. Kudryashov, Alex A. Compton et al. · 2020 · The EMBO Journal
23. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion
    Zang, Ruochen, Case, James Brett, Yutuc, Eylan, Ma, Xiucui, Shen, Sheng, Gomez Castro, Maria Florencia, Liu, Zhuoming, Zeng, Qiru, Zhao, Haiyan, Son, Juhee et al. · 2020 · Proceedings of the National Academy of Sciences
24. An <i>Alphavirus</i> -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates
    Erasmus, Jesse H., Khandhar, Amit P., O’Connor, Megan A., Walls, Alexandra C., Hemann, Emily A., Murapa, Patience, Archer, Jacob, Leventhal, Shanna, Fuller, James T., Lewis, Thomas B. et al. · 2020 · Science Translational Medicine
25. Open resource of clinical data from patients with pneumonia for the prediction of COVID-19 outcomes via deep learning
    Wanshan Ning, Shijun Lei, Jingjing Yang, Yukun Cao, Peiran Jiang, Qianqian Yang, Jiao Zhang, Xiaobei Wang, Fenghua Chen, Zhi Geng et al. · 2020 · Nature Biomedical Engineering
26. Rapid and accurate nucleobase detection using FnCas9 and its application in COVID-19 diagnosis
    Mohd. Azhar, Rhythm Phutela, Manoj Kumar, Asgar Hussain Ansari, Riya Rauthan, Sneha Gulati, Namrata Sharma, Dipanjali Sinha, Saumya Sharma, Sunaina Singh et al. · 2021 · Biosensors and Bioelectronics
27. Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer
    Suresh Varma Kuchipudi, Meera Surendran Nair, Rachel M. Ruden, Michele Yon, Ruth Helmus Nissly, Kurt J. Vandegrift, Rahul K. Nelli, Lingling Li, Bhushan M. Jayarao, Costas D. Maranas et al. · 2022 · Proceedings of the National Academy of Sciences
28. Association of COVID-19 pandemic with meteorological parameters over Singapore
    Shantanu Kumar Pani, Neng‐Huei Lin, Saginela Ravindra Babu · 2020 · The Science of The Total Environment
29. Impact of the coronavirus (COVID-19) pandemic on scientific research and implications for clinical academic training – A review
    Catrin Sohrabi, Ginimol Mathew, Thomas Franchi, Ahmed Kerwan, Michelle Griffin, Jennick Soleil C Del Mundo, Syed Ahsan Ali, Maliha Agha, Riaz Agha · 2021 · International Journal of Surgery
30. Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
    Rolando Cannalire, Carmen Cerchia, Andrea R. Beccari, Francesco Saverio Di Leva, Vincenzo Summa · 2020 · Journal of Medicinal Chemistry
31. Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses
    Yujuan Chen, Junhong Lin, Yao Zhao, Xianping Ma, Huashan Yi · 2021 · Journal of Zhejiang University SCIENCE B
32. Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2
    Saif ur Rehman, Laiba Shafique, Awais Ihsan, Qingyou Liu · 2020 · Pathogens
33. Vaccines for COVID-19: The current state of play
    Archana Koirala, Ye Jin Joo, Ameneh Khatami, Clayton Chiu, Philip N Britton · 2020 · Paediatric Respiratory Reviews
34. Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo
    Hangping Yao, Xiangyun Lu, Qiong Chen, Kaijin Xu, Yu Zheng Chen, Minghui Cheng, Keda Chen, Linfang Cheng, Tian-Hao Weng, Danrong Shi et al. · 2020 · Cell Discovery
35. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
    Erik Alm, Eeva Broberg, Thomas R. Connor, Emma B. Hodcroft, Andrey B. Komissarov, Sebastian Maurer‐Stroh, Angeliki Melidou, Richard A. Neher, Aine Niamh O’Toole, Dmitriy I. Pereyaslov et al. · 2020 · Eurosurveillance
36. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors
    Alina S. Shomuradova, Murad S. Vagida, Savely A. Sheetikov, Ksenia V. Zornikova, Dmitry Olegovych Kiryukhin, Aleksei Titov, Iuliia O. Peshkova, Alexandra A. Khmelevskaya, Dmitry Vladimirovich Dianov, Maria Malasheva et al. · 2020 · Immunity
37. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 + T cell activation in COVID-19 patients
    Sunil Kumar Saini, Ditte Stampe Hersby, Tripti Tamhane, Helle Rus Povlsen, Susana Patricia Amaya Hernandez, Morten Nielsen, Anne Ortved Gang, Sine Reker Hadrup · 2021 · Science Immunology
38. Mobile and wearable sensors for data-driven health monitoring system: State-of-the-art and future prospect
    Chioma Virginia Anikwe, Henry Friday Nweke, Anayo Chukwu Ikegwu, Chukwunonso Adolphus Egwuonwu, Fergus Uchenna Onu, Uzoma Rita Alo, Ying Wah Teh · 2022 · Expert Systems with Applications
39. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
    Sandro La Vignera, Rossella Cannarella, Rosita Angela Condorelli, Francesco Torre, Antônio Aversa, Aldo Eugenio Calogero · 2020 · International Journal of Molecular Sciences
40. Anti-inflammatory potential of Quercetin in COVID-19 treatment
    Ali Saeedi‐Boroujeni, Mohammad‐Reza Mahmoudian‐Sani · 2021 · Journal of Inflammation
41. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
    Manuel Hayn, Maximilian Hirschenberger, Lennart Koepke, Rayhane Nchioua, Jan Hendrik Straub, Susanne Klute, Victoria Hunszinger, Fabian Zech, Caterina Prelli Bozzo, Wasim Aftab et al. · 2021 · Cell Reports
42. Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
    Rachna T. Shroff, Pavani Chalasani, Ran Wei, Daniel Pennington, Grace Quirk, Marta V. Schoenle, Kameron L. Peyton, Jennifer L. Uhrlaub, Tyler J. Ripperger, Mladen Jergović et al. · 2021 · Nature Medicine
43. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach
    Shweta Choudhary, Yashpal Singh Malik, Shailly Tomar · 2020 · Frontiers in Immunology
44. Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms
    Amanat Ali, Ranjit Vijayan · 2020 · Scientific Reports
45. The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology
    Bas B. Oude Munnink, Nathalie Worp, David F. Nieuwenhuijse, Reina S. Sikkema, Bart L. Haagmans, Ron A. M. Fouchier, Marion Koopmans · 2021 · Nature Medicine
46. The role of environmental factors to transmission of SARS-CoV-2 (COVID-19)
    Hadi Eslami, Mahrokh Jalili · 2020 · AMB Express
47. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs
    Lei Sun, Pan Li, Xiaohui Ju, Jian Yu Rao, Wenze Huang, Lili Ren, Shaojun Zhang, Tuanlin Xiong, Kui Xu, Xiaolin Zhou et al. · 2021 · Cell
48. Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
    Mark Dittmar, Jae Seung Lee, Kanupriya Whig, Elisha Segrist, Minghua Li, Brinda Kamalia, Lauren Castellana, Kasirajan Ayyanathan, Fabian L. Cardenas‐Diaz, Edward E. Morrisey et al. · 2021 · Cell Reports
49. First detection and genome sequencing of SARS‐CoV‐2 in an infected cat in France
    Corinne Sailleau, Marine Dumarest, Jessica Vanhomwegen, Manon Delaplace, Valérie Caro, Aurélia Kwasiborski, Véronique Hourdel, Patrick Chevaillier, Alix Barbarino, Loïc Comtet et al. · 2020 · Transboundary and Emerging Diseases
50. Rapid Development of SARS-CoV-2 Spike Protein Receptor-Binding Domain Self-Assembled Nanoparticle Vaccine Candidates
    Yin-Feng Kang, Cong Sun, Zhen Zhuang, Run-Yu Yuan, Qingbing Zheng, Jiang-Ping Li, Pingping Zhou, Xin-Chun Chen, Zhe Liu, Xiao Zhang et al. · 2021 · ACS Nano
51. Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR
    Kentaro Itokawa, Tsuyoshi Sekizuka, Masanori Hashino, Rina Tanaka, Makoto Kuroda · 2020 · PLoS ONE
52. Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2
    Haibo Wu, Na Xing, Kaiwen Meng, Beibei Fu, Weiwei Xue, Pan Dong, Wanyan Tang, Yang Xiao, Gexin Liu, Haitao Luo et al. · 2021 · Cell Host & Microbe
53. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity
    Yuanmei Zhu, Danwei Yu, Hongxia Yan, Huihui Chong, Yuxian He · 2020 · Journal of Virology
54. Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium
    Haijun Zhang, Mahboubeh R. Rostami, Philip L. Leopold, Jason G. Mezey, Sarah L. O’Beirne, Yael Strulovici‐Barel, Ronald G. Crystal · 2020 · American Journal of Respiratory and Critical Care Medicine
55. How can nanotechnology help to combat COVID-19? Opportunities and urgent need
    Estefânia Vangelie Ramos Campos, Anderson do Espírito Santo Pereira, Jhones Luiz de Oliveira, Lucas Bragança Carvalho, Mariana Guilger‐Casagrande, Renata de Lima, Leonardo Fernandes Fraceto · 2020 · Journal of Nanobiotechnology
56. Biomimetic Human Disease Model of SARS‐CoV‐2‐Induced Lung Injury and Immune Responses on Organ Chip System
    Zhang, Min, Wang, Peng, Luo, Ronghua, Wang, Yaqing, Li, Zhongyu, Guo, Yaqiong, Yao, Yulin, Li, Minghua, Tao, Tingting, Chen, Wenwen et al. · 2021 · Advanced Science
57. Emerging SARS-CoV-2 variants of concern and potential intervention approaches
    Jasmin Khateeb, Yuchong Li, Haibo Zhang · 2021 · Critical Care
58. Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
    Zhengnan Shen, Kiira M Ratia, Laura M. Cooper, Deyu Kong, Hyun Lee, Youngjin Kwon, Yangfeng Li, Saad Alqarni, Fei Huang, Oleksii Dubrovskyi et al. · 2021 · Journal of Medicinal Chemistry
59. Vaccines for COVID-19
    John S. Tregoning, E S Brown, Hannah M. Cheeseman, Katie E. Flight, Sophie L. Higham, N-M Lemm, Benjamin F. Pierce, David C. Stirling, Ziyin Wang, Katrina M. Pollock · 2020 · Clinical & Experimental Immunology
60. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches
    Rong Dong, Zhugang Chu, Fuxun Yu, Yan Zha · 2020 · Frontiers in Immunology
61. ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response
    Cheng Wang, Mingzi Zhang, Gustavo Garcia, Erpo Tian, Qi Cui, Xianwei Chen, Guihua Sun, Jinhui Wang, Vaithilingaraja Arumugaswami, Yanhong Shi · 2021 · Cell stem cell
62. Immune responses and pathogenesis of SARS‐CoV ‐2 during an outbreak in Iran: Comparison with SARS and MERS
    Mohsen Rokni, Vida Ghasemi, Zahra Tavakoli · 2020 · Reviews in Medical Virology
63. A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa
    Eduan Wilkinson, Marta Giovanetti, Houriiyah Tegally, James Emmanuel San, Richard John Lessells, Diego F. Cuadros, Darren Patrick Martin, David A. Rasmussen, Abdel‐Rahman N. Zekri, Abdoul Karim Sangaré et al. · 2021 · Science
64. A high-stringency blueprint of the human proteome
    Adhikari, Subash, Nice, Edouard C., Deutsch, Eric W., Lane, Lydie, Omenn, Gilbert S., Pennington, Stephen R., Paik, Young-Ki, Overall, Christopher M., Corrales, Fernando J., Cristea, Ileana M. et al. · 2020 · Nature Communications
65. Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019
    Xiaojing Zou, Shusheng Li, Minghao Fang, Ming Hu, Yi Bian, Jianmin Ling, Shanshan Yu, Liang Jing, Donghui Li, Jiao Huang · 2020 · Critical Care Medicine
66. Remdesivir and its antiviral activity against COVID-19: A systematic review
    Andri Frediansyah, Firzan Nainu, Kuldeep Dhama · 2020 · Clinical Epidemiology and Global Health
67. Inhibitors of SARS-CoV‑2 Entry: Current and Future Opportunities
    Siyu Xiu, Alexej Dick, Han Ju, Sako Mirzaie, Fatemeh Abdi, Simon Cocklin, Peng Zhan, Xinyong Liu · 2020 · Journal of Medicinal Chemistry
68. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression
    Günther Schönrich, Martin J. Raftery, Yvonne Samstag · 2020 · Advances in Biological Regulation
69. Discovery of sandwich type COVID-19 nucleocapsid protein DNA aptamers
    Liyun Zhang, Xiaona Fang, Xingbo Liu, Huichao Ou, Haiyan Zhang, Jin‐Jun Wang, Qian Li, Huanyi Cheng, Wenyi Zhang, Zhaofeng Luo · 2020 · Chemical Communications
70. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China
    Fan Wu, Mei Liu, Aojie Wang, Lu Lu, Qimin Wang, Chenjian Gu, Jun Chen, Yang Wu, Shuai Xia, Yun Ling et al. · 2020 · JAMA Internal Medicine
71. Natural history of COVID-19 and current knowledge on treatment therapeutic options
    Wagner Gouvêa dos Santos · 2020 · Biomedicine & Pharmacotherapy
72. Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
    Wei Jian Zhu, Miao Xu, Catherine Z. Chen, Hui Guo, Min Shen, Xin Hu, Paul Shinn, Carleen A. Klumpp-Thomas, Sam Michael, Wei Zheng · 2020 · ACS Pharmacology & Translational Science
73. COVID-19 Antibody Tests and Their Limitations
    Guoqiang Liu, James F. Rusling · 2021 · ACS Sensors
74. eCovSens-Ultrasensitive Novel In-House Built Printed Circuit Board Based Electrochemical Device for Rapid Detection of nCovid-19 antigen, a spike protein domain 1 of SARS-CoV-2
    Subhasis Mahari, Akanksha Roberts, Deepshikha Shahdeo, Sonu Gandhi · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
75. Bioresponsive drug delivery systems for the treatment of inflammatory diseases
    Yin Dou, Chenwen Li, Lanlan Li, Jiawei Guo, Jianxiang Zhang · 2020 · Journal of Controlled Release
76. Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
    Mohammad Mehdi Ghahremanpour, Julian Tirado‐Rives, Maya G. Deshmukh, Joseph A. Ippolito, Chunhui Zhang, Israel Cabeza de Vaca, Maria-Elena Liosi, Karen S. Anderson, William L. Jorgensen · 2020 · ACS Medicinal Chemistry Letters
77. A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology
    Andrew Rambaut, Edward C. Holmes, Verity Hill, Aine Niamh O’Toole, JT McCrone, Chris Ruis, Louis du Plessis, Oliver G. Pybus · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
78. Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy
    Giordano, Giulia, Colaneri, Marta, Di Filippo, Alessandro, Blanchini, Franco, Bolzern, Paolo, De Nicolao, Giuseppe, Sacchi, Paolo, Colaneri, Patrizio, Bruno, Raffaele · 2021 · Nature Medicine
79. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
    Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang, Yongliang Zhao, Yan Ling Wu, Weijuan Shang, Xiaming Jiang et al. · 2020 · Protein & Cell
80. Review of analytical performance of COVID-19 detection methods
    Basant Giri, Shishir Pandey, Retina Shrestha, Krisha Pokharel, Frances S. Ligler, Bhanu Bhakta Neupane · 2020 · Analytical and Bioanalytical Chemistry
81. On the whereabouts of SARS-CoV-2 in the human body: A systematic review
    Wim Trypsteen, Jolien Van Cleemput, Willem van Snippenberg, Sarah Gerlo, Linos Vandekerckhove · 2020 · PLoS Pathogens
82. Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
    Ye Qiu, Yuanbo Zhao, Qiong Wang, Jinyan Li, Zhijian Zhou, Ce-Heng Liao, Xing‐Yi Ge · 2020 · Microbes and Infection
83. A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition
    M. Eugenia Dieterle, Denise Haslwanter, Robert H. Bortz, Ariel S. Wirchnianski, Gorka Lasso, Olivia Vergnolle, Shawn A. Abbasi, J. Maximilian Fels, Ethan Laudermilch, Catalina Florez et al. · 2020 · Cell Host & Microbe
84. CVDNet: A novel deep learning architecture for detection of coronavirus (Covid-19) from chest x-ray images
    Chaimae Ouchicha, Ouafae Ammor, Mohammed Meknassi · 2020 · Chaos Solitons & Fractals
85. Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium
    Ray W. Izquierdo-Lara, Goffe Elsinga, Leo Heijnen, Bas B. Oude Munnink, Claudia M. E. Schapendonk, David F. Nieuwenhuijse, Matthijs Kon, Lu Lu, Frank M. Aarestrup, Samantha Lycett et al. · 2021 · Emerging infectious diseases
86. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge
    Yfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, Boaz Politi, Ohad Shifman, Hagit Achdout, Einat B. Vitner, Ofir Israeli, Elad Milrot, Dana Stein et al. · 2020 · Nature Communications
87. Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
    Wang, Rui, Chen, Jiahui, Gao, Kaifu, Wei, Guo-Wei · 2021 · Genomics
88. Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
    Anoop Narayanan, Manju Narwal, Sydney A. Majowicz, Carmine Varricchio, Shay A. Toner, Carlo Ballatore, Andrea Brancale, Katsuhiko S. Murakami, Joyce Jose · 2022 · Communications Biology
89. Lessons from Italian front-line nurses' experiences during the COVID-19 pandemic: a qualitative descriptive study.
    G. Catania, M. Zanini, M. Hayter, F. Timmins, N. Dasso, Giulia Ottonello, G. Aleo, Loredana Sasso, A. Bagnasco · 2020 · Journal of Nursing Management
90. CT of Post-Acute Lung Complications of COVID-19
    Solomon, Joshua J., Heyman, Brooke, Ko, Jane P., Condos, Rany, Lynch, David A. · 2021 · Radiology
91. The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
    José Laerte Boechat, Inês Chora, António Morais, Luís Delgado · 2021 · Pulmonology
92. SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response
    Yu-Zhi Fu, Suyun Wang, Zhou-Qin Zheng, Yi Huang, Wei-Wei Li, Zhi-Sheng Xu, Yan‐Yi Wang · 2020 · Cellular and Molecular Immunology
93. Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities
    Matteo Chiara, Anna Maria D’Erchia, Carmela Gissi, Caterina Manzari, Antonio Parisi, Nicoletta Resta, Federico Zambelli, Ernesto Picardi, Giulio Pavesi, David Stephen Horner et al. · 2020 · Briefings in Bioinformatics
94. The glycosylation in SARS-CoV-2 and its receptor ACE2
    Yanqiu Gong, Suideng Qin, Lunzhi Dai, Zhixin Tian · 2021 · Signal Transduction and Targeted Therapy
95. Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection
    Bao, Lirong, Zhang, Cheng, Dong, Jiajia, Zhao, Lei, Li, Yan, Sun, Jianxun · 2020 · Frontiers in Microbiology
96. Increasing host cellular receptor—angiotensin‐converting enzyme 2 expression by coronavirus may facilitate 2019‐nCoV (or SARS‐CoV‐2) infection
    Meng‐Wei Zhuang, Yun Cheng, Jing Zhang, Xuemei Jiang, Li Wang, Jian Deng, Pei‐Hui Wang · 2020 · Journal of Medical Virology
97. Stress and burnout in health care workers during COVID-19 pandemic: validation of a questionnaire
    Negin Talaee, Mohammad Varahram, Hamidreza Jamaati, Alireza Salimi, Mirsaeed Attarchi, Mehdi Kazempour Dizaji, Makan Sadr, Somayeh Hassani, Behrooz Farzanegan, Fateme Monjazebi et al. · 2020 · Journal of Public Health
98. Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution
    Massimo Amicone, Vítor Borges, Maria João Alves, Joana Isidro, Líbia Zé‐Zé, Sílvia Duarte, Luı́s Vieira, Raquel Guiomar, João Paulo Gomes, Isabel Gordo · 2022 · Evolution Medicine and Public Health
99. Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches
    Anuj Kumar, Gourav Choudhir, Sanjeev Kumar Shukla, Mansi Sharma, Pankaj Kumar Tyagi, Arvind Bhushan, Madhu Rathore · 2020 · Journal of Biomolecular Structure and Dynamics
100. Interpretable RNA Foundation Model from Unannotated Data for Highly Accurate RNA Structure and Function Predictions
     Chen, Jiayang, Hu, Zhihang, Sun, Siqi, Tan, Qingxiong, Wang, Yixuan, Yu, Qinze, Zong, Licheng, Hong, Liang, Xiao, Jin, Shen, Tao et al. · 2022